Navigation Links
Surprising discovery: X-rays drive formation of new crystals
Date:1/25/2010

X-rays can do a lot of useful things -- detect broken bones, tumors and dental cavities, analyze atoms in diverse materials and screen luggage at airports -- but who knew they could cause crystals to form?

A team of Northwestern University researchers has discovered that X-rays can trigger the formation of a new type of crystal: charged cylindrical filaments ordered like a bundle of pencils experiencing repulsive forces, which is unknown in crystals. Similar phenomena may occur naturally in biology, such as in the cytoskeleton filaments of cells, which control cell division and migration in cancer metastasis and many other processes.

The results, which will be published this week in the Jan. 29 issue of the journal Science, expand scientific knowledge of crystals, whether from nature, technological devices or the lab, and also open the door to using X-rays to control the structure of materials or to develop novel biomedical therapies.

Crystal formation is usually based on attractive forces between atoms or molecules, making the Northwestern discovery completely unexpected.

"This is a very intriguing and astonishing result," said Samuel I. Stupp, the paper's senior author and Board of Trustees Professor of Chemistry, Materials Science and Engineering, and Medicine. "The filaments are charged so one would expect them to repel each other, not to organize into a crystal. Even though they are repelling each other, we believe the hundreds of thousands of filaments in the bundles are trapped within a network and form a crystal to become more stable."

The discovery of the new crystals was serendipitous. Very early one morning at Argonne National Laboratory, the members of Stupp's research team applied synchrotron X-ray radiation to a solution of peptide nanofibers they were studying. (The peptides are small synthetic molecules that can be used to create new materials.) The researchers saw the solution go from clear to opaque.

"There was a dramatic change in the way filaments scattered the radiation," said first author Honggang Cui, a postdoctoral fellow in Stupp's lab. "The X-rays turned a disordered structure into something ordered -- a crystal."

The X-rays increase the charge of the filaments, and thus a repulsive electrostatic force drives the crystallization -- a hexagonal stacking of filaments. Trapped in a three-dimensional network, the charged bundled filaments are unable to escape from each other. The crystals disappear when the X-rays are turned off, and the material is not significantly damaged by the radiation.

As a result of repulsive forces, the filaments are positioned far apart from each other, with as much as 320 angstroms separating the filaments. This striking feature is not found in ordinary crystals where molecules are less than five angstroms apart.

"There are oceans of water inside the crystal," Stupp said. "More than 99 percent of the structure is water." The researchers also observed that when the concentration of the charged filaments in solution was higher, the same crystals formed spontaneously without the need to expose them to X-rays.


'/>"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
Source:Eurekalert

Related biology technology :

1. The MedZilla Report for September 2009 - Care Grows Again in September and - Surprisingly - Pharma Sales Jobs Up Too
2. Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans.
3. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels
4. Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels
5. QImaging Introduces 64-Bit QCam Driver
6. Novus Biologicals Awards Contract to Biovista Inc. to Drive its Web-Based Novus Explorer Service
7. PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT
8. Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe
9. Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market
10. Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering
11. TOPAZ Technologies Protocols for Animal Studies Software Drives Customer Conversions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill neighborhood, ... strange place for a head lice treatment salon to set ... a Tuscan restaurant and a French bistro on E Madison ... "We aren,t just any old lice clinic, we pride ourselves ... comfortable, and release some of the stigma associated with lice. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can ... adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect ... SalivaLab , the relationship between insulin and other relevant biomarkers can be extensively ...
(Date:2/23/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... the international society for optics and photonics , have been named Fellows of ... individual’s significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, ...
Breaking Biology Technology:
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):